LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Cadila gains on arm getting USFDA's nod for Minocycline Hydrochloride tablets

Cadila gains on arm getting USFDA's nod for Minocycline Hydrochloride tablets (24-Nov-2017)

Cadila Healthcare is currently trading at Rs. 446.85, up by 3.35 points or 0.76% from its previous closing of Rs. 443.50 on the BSE.

The scrip opened at Rs. 443.20 and has touched a high and low of Rs. 450.40 and Rs. 442.20 respectively. So far 32508 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 558.00 on 12-Jun-2017 and a 52 week low of Rs. 329.95 on 26-Dec-2016.

Last one week high and low of the scrip stood at Rs. 454.60 and Rs. 438.05 respectively. The current market cap of the company is Rs. 45781.77 crore.

The promoters holding in the company stood at 74.79%, while institutions and non-institutions held 17.28% and 7.93% respectively.

Cadila Healthcare's wholly owned subsidiary -- Zydus Pharmaceuticals (USA) has received the final approval from the United States Food & Drug Administration (USFDA) to market Minocycline Hydrochloride Extended-Release Tablets in strengths of 45 mg, 80 mg, 90 mg, 105 mg, and 135 mg. Zydus also received the tentative approval for Minocycline Hydrochloride Extended-Release Tablets, 55 mg, 65 mg, and 115 mg.

Minocycline Hydrochloride Extended-Release Tablets are a tetracycline-class drug, indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. It will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 170 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


Top News Today
MTNL investing Rs 190 crore to upgrade services
(21-May-2018)

MTNL investing Rs 190 crore to upgrade servicesMahanagar Telephone Nigam (MTNL) is investing Rs 190 crore to upgrade its services and may also get 4G spectrum, which will support the company to stay relevant in the highly competitive market.MTNL was......click on news to read complete article.

RIL gets environmental clearance for expansion project in Maharashtra
(21-May-2018)

RIL gets environmental clearance for expansion project in MaharashtraReliance Industries (RIL) has received environment clearance for the expansion and optimisation of its petrochemical complex at Nagothane in Raigad district of Maharashtra at an estimated cost of Rs 2,338......click on news to read complete article.

L&T's arm bags two orders from HURL
(21-May-2018)

L&TLarsen & Toubro's (L&T's) wholly owned subsidiary -- L&T Hydrocarbon Engineering (LTHE) in consortium with TechnipFMC has won two significant orders from Hindustan Urvarak and Rasayan......click on news to read complete article.

International Stock News
Asian markets trade firm as US-China trade tensions ease
(21-May-2018)

Asian markets trade firm as US-China trade tensions easeAsian markets are trading mostly in green in early deals on Monday, after fears of a trade war between the U.S. and China receded following weekend developments. U.S. Treasury Secretary Steve Mnuchin said......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.